Clinical Trial Update: To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine [Phase 4]

View source ↗

Summary

A completed Phase 4 trial assessing adherence to a once-daily fixed-dose combination of lamivudine, efavirenz, and didanosine in patients with Acquired immune d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immune Deficiency Syndrome

Drugs mentioned

• Didanosine (didanosine)
• EFAVIRENZ (efavirenz)
• Lamivudine (lamivudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: AIDS | Phase 4 | Status: COMPLETED